These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum? Klein WL; Krafft GA; Finch CE Trends Neurosci; 2001 Apr; 24(4):219-24. PubMed ID: 11250006 [TBL] [Abstract][Full Text] [Related]
3. A "keto-enol" plaque buster mechanism to diminish Alzheimer's β-Amyloid burden. Zoltán O; László P; Éva K; Béla V Biochem Biophys Res Commun; 2020 Oct; 532(1):82-87. PubMed ID: 32828536 [TBL] [Abstract][Full Text] [Related]
4. Solanezumab and the amyloid hypothesis for Alzheimer's disease. Le Couteur DG; Hunter S; Brayne C BMJ; 2016 Dec; 355():i6771. PubMed ID: 28034844 [No Abstract] [Full Text] [Related]
5. Abeta conformational change is central to Alzheimer's disease. Holtzman DM Neurobiol Aging; 2002; 23(6):1085-8. PubMed ID: 12470806 [No Abstract] [Full Text] [Related]
6. Amyloid plaques and amyloid-beta oligomers: an ongoing debate. Lesné S; Kotilinek L J Neurosci; 2005 Oct; 25(41):9319-20. PubMed ID: 16221839 [No Abstract] [Full Text] [Related]
7. Testing times for the "amyloid cascade hypothesis". Hardy J Neurobiol Aging; 2002; 23(6):1073-4. PubMed ID: 12470803 [No Abstract] [Full Text] [Related]
8. Inhibition of amyloid formation: a strategy to delay the onset of Alzheimer's disease. Lansbury PT Curr Opin Chem Biol; 1997 Aug; 1(2):260-7. PubMed ID: 9667848 [TBL] [Abstract][Full Text] [Related]
11. Bioflocculant hypothesis: a partial endorsement. Terry R Neurobiol Aging; 2002; 23(6):1075. PubMed ID: 12470804 [No Abstract] [Full Text] [Related]
12. Abeta as a bioflocculant: implications for the amyloid hypothesis of Alzheimer's disease. Robinson SR; Bishop GM Neurobiol Aging; 2002; 23(6):1051-72. PubMed ID: 12470802 [TBL] [Abstract][Full Text] [Related]
13. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library. Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663 [TBL] [Abstract][Full Text] [Related]
14. Amyloid-beta: a (life) preserver for the brain. Obrenovich ME; Joseph JA; Atwood CS; Perry G; Smith MA Neurobiol Aging; 2002; 23(6):1097-9. PubMed ID: 12470809 [No Abstract] [Full Text] [Related]
15. Plant-based chimeric HPV-virus-like particles bearing amyloid-β epitopes elicit antibodies able to recognize amyloid plaques in APP-tg mouse and Alzheimer's disease brains. Gonzalez-Castro R; Acero Galindo G; García Salcedo Y; Uribe Campero L; Vazquez Perez V; Carrillo-Tripp M; Gevorkian G; Gomez Lim MA Inflammopharmacology; 2018 Jun; 26(3):817-827. PubMed ID: 29094307 [TBL] [Abstract][Full Text] [Related]
16. N-truncated Aβ Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359 [TBL] [Abstract][Full Text] [Related]
17. The amyloid hypothesis: let sleeping dogmas lie? Bishop GM; Robinson SR Neurobiol Aging; 2002; 23(6):1101-5. PubMed ID: 12470810 [TBL] [Abstract][Full Text] [Related]
18. Is amyloid beta-peptide neurotoxic or neuroprotective and what is its role in the binding of metal ions? Savory J; Ghribi O; Herman MM Neurobiol Aging; 2002; 23(6):1089-92. PubMed ID: 12470807 [No Abstract] [Full Text] [Related]